Literature DB >> 30213450

Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer.

Zachary Seymour1, Daniel Hamstra2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30213450     DOI: 10.1016/S1470-2045(18)30567-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease.

Authors:  Ivan Henriquez; Daniel Spratt; Alfonso Gómez-Iturriaga; Oscar Abuchaibe; Felipe Couñago
Journal:  World J Clin Oncol       Date:  2021-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.